Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Lu AH69593 in Healthy Participants (DDI Study)
NCT07775261Phase 1Recruiting
- Sponsor
- Lundbeck
- Start
- Aug 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of Lu AH69593 (3 arms), sponsored by Lundbeck. Primary endpoints: Area Under the Plasma-concentration-time Curve from Zero to Infinity and Maximum Observed Plasma Concentration. Started Aug 2026; status: recruiting.
02
Drugs
Lu AH69593
Beyond the preview
Go deeper on NCT07775261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775261.